Cargando…
Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients
BACKGROUND: Although new individual treatments continue to reshape the landscape of clinical care in patients with lung cancer, most of the progress has been mainly of benefit to patients with lung adenocarcinomas rather than squamous cell lung carcinoma (SQCLC). Our study aimed to determine whether...
Autores principales: | Zhang, Qing, Zhu, Lei, Zhang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369095/ https://www.ncbi.nlm.nih.gov/pubmed/25886585 http://dx.doi.org/10.1186/s12885-015-1056-9 |
Ejemplares similares
-
Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study
por: Chang, Qing, et al.
Publicado: (2021) -
Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung
por: Duan, Jianchun, et al.
Publicado: (2015) -
Cytomorphological features as predictors of epidermal growth factor receptor mutation status in lung adenocarcinoma
por: Sharma, Saniya, et al.
Publicado: (2018) -
Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes
por: Yin, Xin, et al.
Publicado: (2022) -
Epidermal Growth Factor Receptor Mutations and the Clinical Outcome in Male Smokers with Squamous Cell Carcinoma of Lung
por: Park, Se Hoon, et al.
Publicado: (2009)